William Bisson
Title
Cited by
Cited by
Year
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
C Jiang, C Xie, Y Lv, J Li, KW Krausz, J Shi, CN Brocker, D Desai, ...
Nature communications 6 (1), 1-18, 2015
3402015
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
L Sun, C Xie, G Wang, Y Wu, Q Wu, X Wang, J Liu, Y Deng, J Xia, B Chen, ...
Nature medicine 24 (12), 1919-1929, 2018
3272018
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ...
Carcinogenesis 36 (Suppl_1), S254-S296, 2015
2412015
Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles
TD Hubbard, IA Murray, WH Bisson, TS Lahoti, K Gowda, SG Amin, ...
Scientific reports 5 (1), 1-13, 2015
1982015
Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro
AD Benninghoff, WH Bisson, DC Koch, DJ Ehresman, SK Kolluri, ...
Toxicological sciences 120 (1), 42-58, 2011
1782011
Colorectal cancer liver metastasis: evolving paradigms and future directions
LR Zarour, S Anand, KG Billingsley, WH Bisson, A Cercek, MF Clarke, ...
Cellular and molecular gastroenterology and hepatology 3 (2), 163-173, 2017
1632017
Environmental immune disruptors, inflammation and cancer risk
PA Thompson, M Khatami, CJ Baglole, J Sun, SA Harris, EY Moon, ...
Carcinogenesis 36 (Suppl_1), S232-S253, 2015
1542015
Causes of genome instability: the effect of low dose chemical exposures in modern society
SAS Langie, G Koppen, D Desaulniers, F Al-Mulla, R Al-Temaimi, ...
Carcinogenesis 36 (Suppl_1), S61-S88, 2015
1382015
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands
WH Bisson, DC Koch, EF O’Donnell, SM Khalil, NI Kerkvliet, RL Tanguay, ...
Journal of medicinal chemistry 52 (18), 5635-5641, 2009
1312009
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
P Rajendran, AI Kidane, TW Yu, WM Dashwood, WH Bisson, CV Löhr, ...
Epigenetics 8 (6), 612-623, 2013
1132013
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
WH Bisson, AV Cheltsov, N Bruey-Sedano, B Lin, J Chen, N Goldberger, ...
Proceedings of the National Academy of Sciences 104 (29), 11927-11932, 2007
1102007
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
A Sehrawat, L Gao, Y Wang, A Bankhead, SK McWeeney, CJ King, ...
Proceedings of the National Academy of Sciences 115 (18), E4179-E4188, 2018
1032018
The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor
EF O'Donnell, KS Saili, DC Koch, PR Kopparapu, D Farrer, WH Bisson, ...
PloS one 5 (10), e13128, 2010
1002010
Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism
KJ Smith, IA Murray, R Tanos, J Tellew, AE Boitano, WH Bisson, ...
Journal of Pharmacology and Experimental Therapeutics 338 (1), 318-327, 2011
972011
The effect of environmental chemicals on the tumor microenvironment
SC Casey, M Vaccari, F Al-Mulla, R Al-Temaimi, A Amedei, ...
Carcinogenesis 36 (Suppl_1), S160-S183, 2015
962015
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
RB Robey, J Weisz, NB Kuemmerle, AC Salzberg, A Berg, DG Brown, ...
Carcinogenesis 36 (Suppl_1), S203-S231, 2015
892015
Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors
M Ceccon, L Mologni, W Bisson, L Scapozza, C Gambacorti-Passerini
Molecular Cancer Research 11 (2), 122-132, 2013
872013
AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafish
BC Goodale, JK La Du, WH Bisson, DB Janszen, KM Waters, RL Tanguay
PloS one 7 (1), e29346, 2012
872012
α-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells
H Nian, WH Bisson, WM Dashwood, JT Pinto, RH Dashwood
Carcinogenesis 30 (8), 1416-1423, 2009
852009
α-Keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells
JI Lee, H Nian, AJL Cooper, R Sinha, J Dai, WH Bisson, RH Dashwood, ...
Cancer prevention research 2 (7), 683-693, 2009
812009
The system can't perform the operation now. Try again later.
Articles 1–20